Dr. Anton Dormer is the Chairman, CSO, and co-founder of PepVax, Inc. PepVax, Inc., started in 2011, is a drug delivery biotechnology company that is focused on developing treatments targeting cancer and infectious diseases, and gene therapy treatments.

 

PepVax, Inc. proprietary product is called SMARTmid and it was co-developed and co-invited by Dr. Dormer. SMARTmid is an innovative DNA plasmid construct that is presently licensed or in collaboration research projects with several companies and academic institutions.

 

To contact Anton, visit: www.pepvax.co